| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2858411320fb0a2e0a846742666185f9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-20 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-20 |
| filingDate |
1984-10-01^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2524bcecb59df40bebe036dc941b41f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d45b03af0392f74a68d22aa9dbcb9b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3ce45f47387be81191e6cea1973c002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8919bab43a3cd4a02915001f6fdc345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17332e228ca83e586e2dbcacb6c16ca8 |
| publicationDate |
1986-04-04^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2570947-A1 |
| titleOfInvention |
MONOCLONAL ANTI-LEISHMANIA ANTIBODIES, SECRET HYBRIDOMAS THEREOF, LEISHMANIA ANTIGENS RECOGNIZED BY THESE ANTIBODIES, PROCESS FOR OBTAINING AND APPLICATIONS THEREOF |
| abstract |
THE INVENTION CONCERNS HYBRIDOMAS PRODUCING MONOCLONAL ANTI-LEISHMANIA ANTIBODIES WHICH ARE CHARACTERIZED BY THEIR ABILITY TO INHIBIT INFECTION OF SARCOMATOUS CELLS BY THE PROMASTIGOT FORMS OF ONE OR MORE SPECIES OF LEISHMANIA, WHEN IN CONTACT WITH THE SARCOMATOUS FORMES, WHEN IN CONTACT WITH THE SARCOMATOUS FORMES, WHEN THE SARCOMATO CELL PROMASTIGOTES PRE-INCUBATED WITH THESE MONOCLONAL ANTIBODIES UNDER CONDITIONS WHICH, IN THE ABSENCE OF THE SAID MONOCLONAL ANTIBODIES, WOULD LEAD TO A HIGH PARASITEMIA IN THE SAID CELLS. THESE MONOCLONAL ANTIBODIES AND THE PARASITE PROTEINS WHICH THEY RECOGNIZE CAN BE USED IN LEISHMANIOSIS DETECTING OPERATIONS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6491922-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6673351-B1 |
| priorityDate |
1984-10-01^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |